- PROCTO3 REPORT AT Gastroenterology, Hepatobiliary, and Biliary Department - FV HOSPITAL (17/01/2024 )
- GLIGCA REPORT AT SPINE DEPARTMENT B – HCMC ORTHOPEDIC TRAUMA HOSPITAL (17/01/2024 )
- REPORT TAMDEFLO, CAPSER, VOCFOR, DEGODAS CAN THO CENTRAL GERD (17/01/2024 )
- REPORT TAMDEFLO ORTHOPEDIC TRAUMA DEPARTMENT (17/01/2024 )
- CAPSER REPORT FOR MUSCULOSCOPIC AND JOINT DEPARTMENT OF CHO RAY HOSPITAL (17/01/2024 )
- TAMDEFLO MINH DUC HOSPITALOn October 21, 2023, Medbolide Joint Stock Company had a report to introduce the product TAMDEFLO (deflazacort 6mg) at the hall of Minh Duc Hospital, Ben Tre. The report took place with the participation of more than 30 Doc (17/01/2024 )
- Report TAMDEFLO Thong Nhat Hospital (17/01/2024 )
- Report TAMDEFLO MEDIC BINH DUONG (17/01/2024 )
- GLIGCA REPORT AT THE PHARMACY DEPARTMENT - FV HOSPITAL (11/01/2024 )
- CAPSER – ENDOCRINE DEPARTMENT, CHO RAY HOSPITAL (16/10/2023 )
FOGICAP REPORT AT TAM TRI SAIGON HOSPITAL
Wednesday, November 16, 2022, at Tam Tri Saigon Hospital hall.
Medbolide Joint Stock Company had a report introducing the stomach medicine product FOGICAP (Omeprazole and Sodium bicarbonate). The report took place with the participation of more than 40 Doctors and medical staff.
Company representatives presented recommendations and clinical studies demonstrating the effectiveness of FOGICAP, an FDA-approved immediate-release PPI formulation. The drug helps control stomach acid strongly, quickly and continuously for 24 hours. Effective in treating ulcers and gastroesophageal reflux
After the report, the doctors had many discussions about the use and safety of the drug.
At the end of the report, Medbolide Company sends its thanks and hopes to continue accompanying the Hospital in bringing solutions to improve the quality of life for patients.
Readers comments